WO2017194568A1 - Treatment regimen using anti-muc1 maytansinoid immunoconjugate antibody for the treatment of tumors - Google Patents

Treatment regimen using anti-muc1 maytansinoid immunoconjugate antibody for the treatment of tumors Download PDF

Info

Publication number
WO2017194568A1
WO2017194568A1 PCT/EP2017/061103 EP2017061103W WO2017194568A1 WO 2017194568 A1 WO2017194568 A1 WO 2017194568A1 EP 2017061103 W EP2017061103 W EP 2017061103W WO 2017194568 A1 WO2017194568 A1 WO 2017194568A1
Authority
WO
WIPO (PCT)
Prior art keywords
conjugate
cycle
use according
mg
administered
Prior art date
Application number
PCT/EP2017/061103
Other languages
French (fr)
Inventor
Sylvie ASSADOURIAN
Patrick Cohen
Nathalie FAGNIEZ
Alexia TELLIER
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP16305553 priority Critical
Priority to EP16305553.6 priority
Application filed by Sanofi filed Critical Sanofi
Publication of WO2017194568A1 publication Critical patent/WO2017194568A1/en

Links